Smell is the brain’s fastest pathway to emotion and memory — yet it remains one of the most overlooked signals in neurotechnology. In this interview, Lekha Challappa, co-founder of Aurat Aroma, explains how olfactory intelligence can be quantified, modelled, and used to predict human perception. From flavour and fragrance to healthcare and threat detection, she shares why digitised scent could become a critical layer in the future of neurotech and AI.

Omari Bouknight, CEO of Resonant Link Medical, shares how his team is building the wireless backbone for the next generation of implantable devices — from neurostimulation and BCI to cardiac care. In this exclusive interview, he discusses the company’s journey, the Orion platform’s core innovations, and what it takes to bring high-performance power and data transfer into the body.

From lab to clinic, NeuroBionics is redefining neuromodulation with flexible, vascular‑based neural interfaces. In this interview, co‑founder Nicolette Driscoll shares her journey, the technical breakthroughs behind their evStim device, and how they’re pushing neurotechnology forward.

Sam Hosovsky, CEO of uCat, shares his journey into neurotechnology and how his company is transforming brain-computer interface (BCI) development through VR-based training and avatar embodiment. Discover how uCat is helping redefine clinical adoption of BCIs.